Thus, liver KLB knockdown impaired the beneficial effect of KD on ameliorating hepatic steatosis, particularly by suppressing lipogenesis, suggesting that FGF21-KLB signaling might be critical for KD-ameliorated hepatic steatosis. The gene discussed is FGF21; the disease is Hepatic steatosis.